RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
112 hedge funds and large institutions have $471M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 28 closing their positions.
86% more capital invested
Capital invested by funds: $252M → $471M (+$218M)
80% more call options, than puts
Call options by funds: $17.6M | Put options by funds: $9.77M
68% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 28
20% more funds holding
Funds holding: 93 → 112 (+19)
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$28.9M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$28.2M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$27.1M |
| 4 |
WIC
Water Island Capital
New York
|
+$23.9M |
| 5 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$13.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$41.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$24M |
| 3 |
Goldman Sachs
New York
|
-$16.8M |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$15.4M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$8.87M |
RPTP Hedge Fund Activity: Q3 2016 in Review
112 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2016, worth a combined $471M — up 86% from $252M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new RPTP positions and 28 closed out — a net gain of 19 holders — while 26 added to existing stakes and 26 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $28.9M. The largest seller was Broadfin Capital, cutting an estimated $41.1M.
- 112 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2016, up from 93 in Q2 2016.
- Funds reported $471M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2016, up 86% quarter-over-quarter.
- 47 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2016 and 28 closed out, a net change of +19 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2016 was AQR Arbitrage, an estimated $28.9M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2016 was Broadfin Capital, an estimated $41.1M sold.
Based on aggregated 13F filings for Q3 2016.